Global Next Generation Sequencing (NGS) Market Research Report 2021 - Impact of COVID-19 on the Market

Next generation sequencing (NGS) is also known as high-throughput and massive parallelization sequencing technology. In the NGS process, genetic material is extracted, fragmented, and linked to adapters and primers for the amplification reaction (PCR) for library construction. Sequencing of the fragmented genetic material is executed, NGS furnishes a massive set of sequence data in a very small duration.
The Next Generation Sequencing (NGS) market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Next Generation Sequencing (NGS) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Next Generation Sequencing (NGS) Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Next Generation Sequencing (NGS) market are:
Lucigen
Qiagen N.V.
Beijing Genomics Institute
Genomatix GmbH
Thermo Fisher Scientific, Inc.
454 Life Sciences Corporation (Roche Holding AG)
Oxford Nanopore Technologies
PierianDx
Hamilton Company
Agilent Technologies, Inc
Illumina, Inc.
Macrogen
Perkinelmer, Inc
Pacific Biosciences of California, Inc.
QIAGEN

Most important types of Next Generation Sequencing (NGS) products covered in this report are:
Consumables
Platforms
Services
Sequencing Services
Bioinformatics

Most widely used downstream fields of Next Generation Sequencing (NGS) market covered in this report are:
Academic and Clinical Research Centers
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Other End User

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026